Cardiovascular Immunotherapy

Our mission is to investigates the role of immune cells in cardiovascular diseases, including atherosclerosis, peripheral artery disease (PAD), and heart failure, with a particular focus on the cellular and molecular pathways that regulate inflammation, vascular injury, and tissue repair. The research examines how specific immune cell subsets—particularly myeloid and lymphoid populations—drive disease progression or, conversely, promote resolution and healing. We integrate human tissue analysis with mechanistic studies in preclinical models to define the phenotype, function, and localisation of immune cells within diseased vessels and myocardium. These insights allow us to dissect causative mechanisms and test new therapeutic concepts

Our research aims to design and evaluate novel immunotherapies that precisely modulate immune responses, reduce vascular inflammation, enhance tissue repair, and prevent adverse cardiac events. By bridging fundamental immunology with translational research, we seek to advance the understanding of immune–vascular interactions and deliver targeted strategies that improve cardiovascular health and patient outcomes.